临床肿瘤学杂志

• 论著 • 上一篇    下一篇

顺铂不同化疗模式对卵巢癌细胞SKOV3血管生成拟态能力的影响及其机制的探讨

吴小华,陈琳,孙亚楠   

  1. 050082 石家庄 白求恩国际和平医院妇产科
  • 收稿日期:2016-04-04 修回日期:2016-06-05 出版日期:2016-08-31 发布日期:2016-08-31

Effects of different cisplatin chemotherapy patterns on vasculogenic mimicry of ovarian cancer cell SKOV3 and the possible mechanisms

WU Xiaohua,CHEN Lin,SUN Yanan   

  1. Department of Gynecology and Obstetrics, Bethune International Peace Hospital of People’s Liberation Army, Shijiazhuang 050082, China
  • Received:2016-04-04 Revised:2016-06-05 Online:2016-08-31 Published:2016-08-31

摘要: 目的 观察接受顺铂低剂量连续化疗(LDM)和最大可耐受剂量化疗(MTD)后卵巢上皮癌SKOV3细胞的血管生成拟态(VM)的形成能力,并探讨其可能机制。方法 建立卵巢癌SKOV3细胞裸鼠移植瘤模型,分别采用顺铂LDM和MTD模式对裸鼠移植瘤进行治疗,以未化疗小鼠作为对照组;化疗结束取移植瘤培养原代细胞。三维细胞培养观察比较LDM组、MTD组和对照组原代细胞形成VM的能力;MTT法和Transwell侵袭实验分别检测SKOV3移植瘤原代细胞的增殖和侵袭能力;Western blotting检测原代细胞中CD133和乙醛脱氢酶(ALDH1)的表达;收集经流式细胞荧光分选技术(FCAS)分选的CD133+ALDH1+和CD133-ALDH1-细胞行三维细胞培养观察并比较两组形成VM的能力。结果 MTD组和LDM组的抑瘤率分别为25.87%和51.52%。MTD组、对照组和LDM组形成VM的平均时间分别为6、9和12 h;48 h后MTD组、对照组和LDM组的VM密度分别为(29.60±9.55)个、(18.70±4.97)个和(11.20±2.60)个,差异有统计学意义(P<0.05)。从第3天开始MTD组细胞增殖率显著高于对照组和LDM组(P<0.05)。Transwell侵袭实验结果显示,MTD组细胞穿膜数为156.93±22.77,对照组为112.13±16.59,LDM组为87.33±19.58,组间差异有统计学意义(P<0.05)。MTD组CD133、ALDH1蛋白的相对表达量分别为0.402±0.034、0.418±0.020,对照组为0.338±0.046、0.325±0.011,LDM组为0.296±0.042、0.318±0.012,3组间差异有统计学意义(P均<0.05)。以5×104个/ml接种CD133+ALDH1+细胞6 h左右形成VM,CD133-ALDH1-细胞48 h仍未形成VM;以1×105个/ml接种CD133-ALDH1-细胞24 h可形成少量VM。结论 较MTD模式而言,LDM模式可能通过减少高表达CD133+ALDH1+的细胞以影响肿瘤血供进而减少传统模式化疗后肿瘤的耐药和复发。

Abstract: Objective To explore the effects of low-dose metronomic chemotherapy(LDM)and maximum tolerated-dose chemotherapy(MTD)on vasculogenic mimicry(VM)of ovarian epithelial cancer cell SKOV3 and the possible mechanisms. Methods The primary tumor cells were obtained through injecting cisplatin by different chemotherapy schedules(LDM,MTD and control group without chemotherapy)in the nude mice bearing SKOV3 ovarian cancer xenografts. Three groups of primary cells were cultured in threedimensional cell culture model to compare the VM formation ability. The proliferative and invasive ability of each group was evaluated by MTT and Transwell chamber test in vitro respectively. The expression level of CD133 and aldehyde dehydrogenase1(ALDH1)in the primary cells were analyzed by Western blotting and VM formation differences of CD133+ALDH1+cells and CD133-ALDH1-cells were observed by fluorescence-activated cell sorting(FACS). Results The tumor inhibition rates of MTD group and LDM group were 25.87% and 51.52%. Primary tumor cells formed VM in MTD group in only about 6 hours, while in control group and LDM group were 9 hours and 12 hours respectively. After 48 h,the vasculogenic mimicry density(VMD)of MTD group,control group and LDM group was 29.60±9.55,18.70±4.97 and 11.20±2.60,with statistical significance(P<0.05). Compared to LDM group and control group,the cell proliferation of MTD group was significantly higher from the third day(P<0.05). Transwell chamber test showed that the cells of LDM group got through the maxtrix film was 87.33±19.58,much less than 156.93±22.77 of MTD group and 112.13±16.59 of control group(P<0.05). Western blotting suggested that the levels of CD133 and ALDH1 proteins in primary tumor cells of MTD group were 0.402±0.034 and 0.418±0.020,in control group were 0.338±0.046 and 0.325±0.011,in LDM group were 0.296±0.042 and 0.318±0.012. The differences among the 3 groups had statistic significance(P<0.05). When CD133+ALDH1+cells and CD133-ALDH1-cells were cultured with the same density of 5×104/ml,the former formed VM within 6 h,while the latter did not form any after 48 h. Little VM was observed after 24 h when CD133-ALDH1-cells were cultured with the density of 1×105/ml. Conclusion The tumor cells with partial tumor stem cell properties to be enriched easier in MTD than in LDM probably. These cells could influence the tumor blood supply and result in bad prognosis.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!